New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Antifibroblastic Medication in Dermatology: Could Nintedanib Treat Scarring?

Published:2022-09 Issue: Volume:Volume 15 Page:7169-7172
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Cristodor Patricia Liana,Nechifor Alexandru^ORCID,Fotea Silvia,Nadasdy Thomas^ORCID,Bahloul Yousef^ORCID,Nicolescu Alin Codrut^ORCID,Tatu Alin Laurentiu^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference17 articles.

1. Single- and Multiple-Dose Pharmacokinetics of Pirfenidone, an Antifibrotic Agent, in Healthy Chinese Volunteers

2. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly

3. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts

4. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Telangiectasias with Other Peripheral Vascular Lesions of Systemic Sclerosis;Clinical, Cosmetic and Investigational Dermatology;2024-01

2. Immunologic and nonimmunologic sclerodermal skin conditions - review;Frontiers in Immunology;2023-07-12

3. Extracellular Targets to Reduce Excessive Scarring in Response to Tissue Injury;Biomolecules;2023-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP